Biggest News Aggregation in the World
📰 Vertice Pharma News

Page 2 - Vertice Pharma News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Vertice Pharma. Real-time updates on events, politics, business and more.

Pharmacokinetic Study Confirming the Bioequivalence of a Novel Oral Solution of Levothyroxine (Thyquidity™) to Synthroid® Presented at The 90th Annual Meeting of the American Thyroid Association

/PRNewswire/ -- Vertice Pharma announces the results of a recent study demonstrating the bioequivalence of Thyquidity™, an oral liquid solution of...
Berkeley Heights New Jersey United States New Providence United Kingdom Endocrinol Lausanne

Afrezza Quarterly Sales Increase, New Therapies on Horizon at MannKind | San Fernando Valley Business Journal

MannKind Corp. touted increased sales for its flagship drug Afrezza during its fourth quarter earnings report on Thursday, while pointing out its new direction toward therapies for lung and endocrine diseases. During the quarter, MannKind pulled in $10.1 million in revenue for Afrezza, its inhalable insulin, a 30 percent increase compared to sales in the same quarter of 2019. The Westlake Village biotech company reported an adjusted net loss of $13.2 million (-6 cents a share). That’s narrowe...
New Jersey United States Michael Castagna Amy Stulick Vertice Pharma Mannkind Corp
Source: sfvbj.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

autoimmune hemolytic anemia treatment Market is Projected to Grow Massively in Near Future – KSU

The  autoimmune hemolytic anemia treatment Market research report thoroughly explains each and every aspect related to the Global autoimmune hemolytic anemia treatment Market, which facilitates the report’s reader to study and evaluate the upcoming market trend and execute the analytical data to promote the business. autoimmune hemolytic anemia treatment Market Insight: Global Autoimmune hemolytic anemia Treatment Market is growing at a steady CAGR in the forecast period of 2019-2026. Incre...
United States Hong Kong United Kingdom South Africa Saudi Arabia Zydus Cadila

Vertice launches THYQUIDITY™ (levothyroxine sodium) Oral Solution

Vertice Pharma ("Vertice"), a specialty pharmaceuticals company focused on improving patients' health, today announced the launch of THYQUIDITY. THYQUIDITY is indicated as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism and as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer.*
Thyroid Gland Thyroid Hormone Vertice Pharma Mannkind Corporation தைராய்டு சுரப்பி தைராய்டு ஹார்மோன்
Source: yahoo.com

Vertice Pharma Names Sandra Miceli Chief Financial Officer

Vertice Pharma Names Sandra Miceli Chief Financial Officer News provided by Share this article Share this article NEW PROVIDENCE, N.J., Dec. 16, 2020 /PRNewswire/ -- Vertice Pharma, a specialty pharmaceuticals company focused on improving patients health, today announced that Sandra Miceli will join the Company as Chief Financial Officer ("CFO"), reporting to Scott Meyers, Chief Executive Officer ("CEO"). Ms. Miceli brings over 25 years of experience in successful pharmaceutical growth compani...
United States New Jersey United Kingdom Sandra Miceli Scott Meyers Vertice Pharma

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science